RBM8A and mesothelioma: In addition, RBM8A silencing in MSTO-211H mesothelioma cells reduced cell viability and induced apoptosis [11], consistent with the analysis of the Dependency Map Project (https://depmap.org/portal/depmap/, accessed on 21 October 2020 [12,13]), which revealed that RBM8A silencing is synthetically lethal in most of the cancer cell lines.